Impact of EPclin on adjuvant therapeutic decision making and comparison of EPclin to the PREDICT tool.

Héloïse Bourien Véronique QuillienFlorence GodeyChristophe PerrinFanny Le DuSophie GuillermetJérôme BlanchotVincent LavouéBoris Campillo-GimenezAngélique BrunotLaurence CrouzetThibault De la Motte RougeVéronique DiérasClaudia Lefeuvre-Plesse

Published in: The International journal of biological markers (2021)

Although genomic tests were developed in order to de-escalate adjuvant treatment, in our comprehensive cancer center the use of the EndoPredict® assay led to an increase in prescribed chemotherapy.

Keyphrases

early stage
decision making
papillary thyroid
high throughput
squamous cell
copy number
gene expression
radiation therapy
lymph node metastasis
dna methylation
childhood cancer